Vancomycin Hydrochloride for Injection, USP. 750 mg. Sterile Powder. Rx Only. Hospira, Inc., Lake Forest, IL 60045 USA. NDC: 0409-6531-02

Presence of Particulate Matter: glass particulate found in vial

Recall #: D-0123-2018
Affected scope: 102,500 vials
Initiated: August 30, 2017

Compiled from official public sources by the publisher. · Updated September 2026

Pfizer Inc. recalled Vancomycin Hydrochloride for Injection, USP. 750 mg. Sterile Powder. Rx Only. Hospira, I… - a critical-severity action.

Vancomycin Hydrochloride for Injection, USP. 750 mg. Sterile Powder. Rx Only. Hospira, I… was recalled by Pfizer Inc. in December 27, 2017. Reason: Presence of Particulate Matter: glass particulate found in vial. Check the official notice for the remedy. Verify recall #D-0123-2018 with the FDA Drug before acting.

The recall

Pfizer Inc. issued this critical-severity FDA Drug recall-Presence of Particulate Matter: glass particulate found in vial.

Critical
severity level: Class I
classification: December 27, 2017
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-0123-2018 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 6 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified high severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

Vancomycin Hydrochloride for Injection, USP. 750 mg. Sterile Powder. Rx Only. Hospira, Inc., Lake Forest, IL 60045 USA. NDC: 0409-6531-02

Reason for recall

Presence of Particulate Matter: glass particulate found in vial

Recall Profile

Structured summary of the FDA Drug recall record
Attribute	Value
Agency	U.S. Food and Drug Administration
Severity class	Critical (Class I)
Status	Terminated
Recall number	D-0123-2018
Date reported	December 27, 2017
Date initiated	August 30, 2017
Recalling firm	Pfizer Inc.
Firm location	New York, NY
Affected scope	102,500 vials
Distribution	Nationwide USA and Puerto Rico

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

Check the recall number (D-0123-2018) and product description against the item you own. Search the archive
Confirm the current status with FDA Drug before acting, recall details can be updated.
This is a Class I (high-risk) recall, stop using the product immediately and follow the disposal or return instructions. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled? ▼

Vancomycin Hydrochloride for Injection, USP. 750 mg. Sterile Powder. Rx Only. Hospira, Inc., Lake Forest, IL 60045 USA. NDC: 0409-6531-02. Recalled by Pfizer Inc.. Units affected: 102,500 vials.

Why was this product recalled? ▼

Presence of Particulate Matter: glass particulate found in vial

Which agency issued this recall? ▼

This recall was issued by the FDA Drug on December 27, 2017. Severity: Critical. Recall number: D-0123-2018.

Where was the recalled product distributed? ▼

Distribution: Nationwide USA and Puerto Rico.

Should I stop using a recalled medication or medical device? ▼

Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Drug and device notices outside this firm and state, matched by severity timing and product category.

Similar severity · nearest report date

Same archive severity grade (Critical), closest by report date among other firms and states.

NitroGlycerin 1 mg/10 mL in 5% Dextrose I… 2017-12-27 NitroGlycerin (1 mg/5 mL) 1 mg in 5% Dext… 2017-12-27 NitroGlycerin (2 mg/10 mL in 5% Dextrose … 2017-12-27 LaBri's Body Health Atomic 60 Capsules Ex… 2017-12-27

Similar Drugs & Medications · nearest report date

Same product category, closest by report date among other firms and states (deduped against the severity set).

Methylphenidate Hydrochloride Extended-re… 2017-12-27 Methylphenidate Hydrochloride Extended-re… 2017-12-27 0.25% Acetic Acid Irrigation USP, 500 mL … 2017-12-27 Fluconazole Injection, USP, 2 mg/mL, a) 5… 2017-12-27

Compare this recall with Kian Pee Wan Capsules, 30-count bottles → · All Drugs & Medications recalls

This recall: FDA Drug, reported December 27, 2017. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026